GE Marquette wins awards, signs GPO contract
GE Marquette Medical Systems has garnered two awards from research firm Frost & Sullivan for its use of market research: the Competitive Strategy Award and the Product Line Strategy Award.These awards are based on independent research and analysis of
GE Marquette Medical Systems has garnered two awards from research firm Frost & Sullivan for its use of market research: the Competitive Strategy Award and the Product Line Strategy Award.
These awards are based on independent research and analysis of companies in the healthcare industry. GE Marquette stood out as a sole-source provider of clinical information systems and devices for patient monitoring and cardiology, and the company has been recognized for forming Web-based alliances to keep it competitive, according to Mahpara Qureshi, Frost & Sullivan industry analyst.
GE Marquettes alliances with companies that produce technology complementary to its own products include Draeger, Critikon, NEC Medical Systems, CardioDynamics, Novametrix, Micro Medical, Data Critical, and Aspect Medical Systems. Wisconsin-based GE Marquettes products focus on diagnostic cardiology, patient monitoring, and clinical information systems.
Recently, GE Marquette signed a three-year contract with Consorta Catholic Resource Partners to provide patient monitoring systems and services to its 900 hospitals and clinics around the world.
Under this agreement, GE Marquette will be a preferred provider of patient monitoring solutions, including the Solar family of advanced vital sign monitoring systems, the Eagle model configured monitors, and the portable Dash monitor, which supports continuous patient monitoring during an ambulance or aircraft ride.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
